We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current 0R34 market cap is 348.57B. The company's latest EPS is USD 14.6028 and P/E is 9.91.
| Year End December 30 2023 | 2019 | 2021 | 2022 | 2023 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 82.06B | 82.58B | 93.78B | 94.94B | 85.16B |
| Operating Income | 19.81B | 19.49B | 23.4B | 23.38B | 21.21B |
| Net Income | 15.12B | 14.71B | 20.88B | 17.94B | 35.15B |
| Year End December 30 2023 | 2019 | 2021 | 2022 | 2023 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 157.73B | 174.89B | 182.02B | 187.38B | 167.56B |
| Total Liabilities | 98.26B | 111.62B | 108B | 110.57B | 98.78B |
| Total Equity | 59.47B | 63.28B | 74.02B | 76.8B | 68.77B |
| Year End December 30 2023 | 2019 | 2021 | 2022 | 2023 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 23.42B | 23.54B | 23.41B | 21.19B | 22.79B |
| Investing | -6.19B | -20.83B | -8.68B | -12.37B | 878M |
| Financing | -18.02B | -6.12B | -14.05B | -8.87B | -15.83B |
| Market Cap | 348.57B |
| Price to Earnings Ratio | 9.91 |
| Price to Sales Ratio | 4.09 |
| Price to Cash Ratio | 15.94 |
| Price to Book Ratio | 5.07 |
| Dividend Yield | - |
| Shares Outstanding | 2.41B |
| Average Volume (1 week) | 6.97k |
| Average Volume (1 Month) | 8.1k |
| 52 Week Change | -10.62% |
| 52 Week High | 167.70 |
| 52 Week Low | 141.50 |
| Spread (Intraday) | 10.4 (6.93%) |
| Company Name | Johnson & Johnson |
| Address |
one johnson & johnson plaza new brunswick, new jersey 08933 |
| Website | https://www.jnj.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
